SCHEMBL8713815

SCHEMBL8713815

CC(=O)Nc1ccc(C(=O)N(CCN2CCC(C(=O)c3ccc(F)cc3)CC2)c2ccccc2C(F)(F)F)cc1

nearest known ligand 0.50

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
SMN1; SMN2 Q16637 3/20 0.48
LMNA P02545 2/20 0.48
HTT P42858 1/20 0.48
ALDH1A1 P00352 1/20 0.48
HTR2A P28223 2/20 0.44
KDM4E B2RXH2 1/20 0.44
CYP1A2 P05177 1/20 0.44
CYP3A4 P08684 1/20 0.44
CYP2D6 P10635 1/20 0.44
HTR2C P28335 1/20 0.44
HTR7 P34969 1/20 0.44
HTR6 P50406 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Fumaric Acid SCHEMBL8712103 0.95 SMN1; SMN2 (0.47) MEN1KMT2ASMN1; SMN2LMNAHTT
Fumaric Acid SCHEMBL8712106 0.95 SMN1; SMN2 (0.47) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL8713319 0.87 CYP2C19 (0.54) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL8711222 0.87 HTR2A (0.48) HTR2AKDM4ECYP1A2CYP3A4CYP2D6
SCHEMBL9229363 0.87 MEN1 (0.49) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL8711420 0.86 SMN1; SMN2 (0.56) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL8710975 0.86 KMT2A (0.48) MEN1KMT2ASMN1; SMN2LMNAHTT
Oxalic Acid SCHEMBL8711790 0.85 CYP2C19 (0.51) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL8711438 0.85 SMN1; SMN2 (0.56) MEN1KMT2ASMN1; SMN2LMNAHTT
SCHEMBL8711392 0.84 HTR2A (0.53) HTR2AKDM4ECYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5728835-A HYPOTENSIVE AGENTS; ANTIISCHEMIC AGENTS TOA EIYO, LTD. (JP) 1998-03-17 US disclosed
EP-0661266-A1 Substituted cyclic amine compounds as 5HT2 antagonists TOA EIYO LTD. (JP) 1995-07-05 EP disclosed